Teva Launches Generic Pulmicort Respules
Pulmicort Respules are indicated as maintenance treatment to control and prevent asthma symptoms in patients aged 12 months–8 years.
Budesnide is an anti-inflammatory corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity. Corticosteroids have been shown to have a wide range of inhibitory activities against multiple cell types (eg, mast cells, eosinophils, neutrophils, macrophages, lymphyocytes), and mediators (eg, histamine, eicosanoids, leukotrienes, and cytokines) involved in allergic- and non-allergic-mediated inflammation.
Budesonide Inhalation Suspension is available as a 1mg/2mL strength in 30-count (6 x 5 ampules) cartons.
For more information call (888) 838-2872 or visit TevaGenerics.com.